Angeliq (drospirenone and estradiol) is a hormone replacement therapy combining an estrogen and progestin designed specifically for postmenopausal women to treat moderate to severe vasomotor symptoms and vulvar and vaginal atrophy. This continuous combined therapy provides effective relief from menopausal symptoms while offering endometrial protection through the progestin component. For women seeking affordable hormone replacement options, working with qualified healthcare providers ensures proper evaluation, appropriate hormone selection, and ongoing monitoring for both therapeutic benefits and potential risks associated with menopausal hormone therapy management.
